Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
5
×
boston top stories
clinical trials
fda
5
×
life sciences
national blog main
investing
boston
deals
national top stories
san francisco blog main
san francisco top stories
biotech ipos
cancer immunotherapy
chronic kidney disease
ipo
medical device
national
new york blog main
new york top stories
san diego blog main
san diego top stories
ulcerative colitis
480 biomedical
acute myeloid leukemia
alx oncology
arsenal medical
autoimmune diseases
berkeley lights
biofourmis
biovotion
bob langer
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer drugs
cancer vaccine
cd47
What
raised
5
×
ipo
million
therapeutics
new
biotech
companies
company
developing
life
momentum
public
science
treat
week
analytics
arrival
biofourmis
biotechs
brings
club
continued
crop
data
days
debut
devices
digital
disorders
drug
dyne
dyne’s
employs
exceeded
firms
genetic
globally
group
hasn’t
haul
Language
unset
Current search:
fda
×
biotech
×
raised
×
" boston blog main "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M